3-deoxyglucosone has been researched along with glucagon-like peptide 2 in 1 studies
| Studies (3-deoxyglucosone) | Trials (3-deoxyglucosone) | Recent Studies (post-2010) (3-deoxyglucosone) | Studies (glucagon-like peptide 2) | Trials (glucagon-like peptide 2) | Recent Studies (post-2010) (glucagon-like peptide 2) |
|---|---|---|---|---|---|
| 186 | 8 | 77 | 798 | 64 | 442 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Huang, F; Jiang, G; Liang, G; Song, X; Xu, H; Yin, M; Zhang, L; Zhou, L | 1 |
1 other study(ies) available for 3-deoxyglucosone and glucagon-like peptide 2
| Article | Year |
|---|---|
Alteration of Intestinal Microbiota in 3-Deoxyglucosone-Induced Prediabetic Rats.
Topics: Administration, Oral; Animals; Deoxyglucose; Gastrointestinal Microbiome; Glucagon-Like Peptide 2; Glucose Tolerance Test; Lipopolysaccharides; Male; Prediabetic State; Rats, Sprague-Dawley; RNA, Ribosomal, 16S | 2020 |